Interne link ProQR Receives Fast Track Designation from the FDA for QR-110 for Leber’s Congenital Amaurosis Type 10 mei 31, 2017 om 11:00 AM UTC
Interne link ProQR remembers co-founder Henri Termeer after his unexpected passing mei 15, 2017 om 11:00 AM UTC
Interne link ProQR to Present its Ophthalmology Pipeline at ARVO, Highlighting Programs in Leber’s Congenital Amaurosis Type 10 (LCA 10) and Usher Syndrome mei 01, 2017 om 11:00 AM UTC
Interne link ProQR Announces Clearance of IND Application to Start Clinical Trial for QR-110 in Leber’s Congenital Amaurosis Type 10 Patients april 27, 2017 om 11:00 AM UTC
Interne link ProQR to Present at the Deutsche Bank Health Care Conference april 20, 2017 om 11:00 AM UTC
Interne link ProQR Announces the Grant of two Key Patents, protecting QR-010 for Cystic Fibrosis in the US and EU april 03, 2017 om 11:00 AM UTC
Interne link ProQR Appoints David M. Rodman, MD as Chief Development Strategy Officer maart 27, 2017 om 11:00 AM UTC
Interne link ProQR to Present at Two Upcoming Investor Conferences in March maart 01, 2017 om 12:00 PM UTC
Interne link ProQR Announces Results for the Fourth Quarter and Full Year 2016 and Provides a Business Update februari 28, 2017 om 12:00 PM UTC
Interne link On a Shared Quest to Find Treatments for Rare Diseases, ProQR Supports Rare Disease Day februari 27, 2017 om 12:00 PM UTC
Interne link ProQR to Present at the LEERINK Partners Global Healthcare Conference februari 07, 2017 om 12:00 PM UTC
Interne link ProQR Announces R&D Day and Provides Update on Innovation Portfolio november 30, 2015 om 12:00 PM UTC
Interne link ProQR Announces Results for the Third Quarter of 2015 and Provides Update on Clinical Trials november 23, 2015 om 11:30 AM UTC
Interne link ProQR Announces an Investor and Analyst Event and Pre-Clinical Data Presentations for QR-010 for Cystic Fibrosis at Two Upcoming Scientific Conferences oktober 01, 2015 om 11:00 AM UTC
Interne link ProQR to Present at the Leerink Partners 4th Annual Rare Disease Roundtable september 23, 2015 om 11:00 AM UTC
Interne link ProQR Announces a Proof-of-Concept Nasal Potential Difference Study of QR-010 is Open for Enrollment september 14, 2015 om 11:00 AM UTC
Interne link ProQR Announces Results for the Second Quarter of 2015 augustus 19, 2015 om 11:59 AM UTC
Interne link ProQR Announces Enrollment Has Started in Global Phase 1b Study of QR-010 in Cystic Fibrosis Patients juni 26, 2015 om 11:54 AM UTC
Interne link ProQR to Present at the JMP Securities Life Science Conference juni 16, 2015 om 11:00 AM UTC
Interne link ProQR Therapeutics Announces Results for the First Quarter of 2015 mei 21, 2015 om 11:00 AM UTC
Interne link ProQR to Present at Two Upcoming Investor Conferences in May april 29, 2015 om 11:00 AM UTC